PLIVA d.d. (ZSE: PLVA-R-A; “PLIVA” or “the Company”) announces that the Company’s Annual General Shareholders' Meeting that was held in Zagreb today, 26 August 2008, made the following resolutions: // 08/26/08

PLIVA d.d. (ZSE: PLVA-R-A), a subsidiary of Barr Pharmaceuticals, Inc. (“Barr”), today reported financial results for the six month period ended 30 June 2008, prepared in accordance with International Financial Reporting Standards (IFRS). // 08/08/08

PLIVA d.d. announced today that further to its announcement on 20 June 2008, the UK Financial Services Authority has cancelled the listing of PLIVA's securities on the London Stock Exchange, effective 22 July 2008. The ordinary shares of PLIVA d.d. will continue to be listed on the Zagreb Stock Exchange. // 07/25/08

PLIVA d.d. notes today’s announcement made by Barr Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd. that they have signed a definitive agreement under which Teva will acquire Barr, which is enclosed with this announcement. // 07/18/08